摘要 |
Disclosed is a compound represented by the formula (1) below having a strong Rho kinase inhibitory activity, a salt thereof or a derivative of any of them as a prodrug. (In the formula (1) below, A represents a nitrogen-containing saturated ring; m represents a number of 0-2; n represents a number of 1-4; G<SUP>1</SUP> represents a hydrogen atom, a chlorine atom, a hydroxy group, an alkoxy group or an amino group; G<SUP>2</SUP> represents a halogen atom, a hydroxy group, a cyano group, a carboxy group, an alkyl group, an alkenyl group or the like; G<SUP>3</SUP> represents a hydrogen atom, a halogen atom, a hydroxy group, a cyano group, a carboxy group, an alkyl group, an alkenyl group or the like; Y represents a single bond or -C(R3)(R4)- (wherein R3 and R4 represent a hydrogen atom or alkyl group, or alternatively they combine together to form a saturated hydrocarbon ring group); G<SUP>4</SUP> represents a hydroxy group (provided that Y is a single bond) or -N(R1)(R2) (wherein R1 and R2 represent a hydrogen atom, an alkyl group, an aralkyl group, an alkenyl group or the like; and G<SUP>5</SUP> represents a substituent at a carbon atom constituting the ring A, which is specifically a hydrogen atom, a fluorine atom or an alkyl group.) |
申请人 |
ASAHI KASEI PHARMA CORPORATION;MATSUBARA, KOKI;IESATO, ATSUSHI;OOMURA, AKIHUMI;KAWASAKI, KOH;YAMADA, RINTARO;SETO, MINORU |
发明人 |
MATSUBARA, KOKI;IESATO, ATSUSHI;OOMURA, AKIHUMI;KAWASAKI, KOH;YAMADA, RINTARO;SETO, MINORU |